Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Unilabs Sweden Launches Subtle Medical's AI-powered Imaging Technology to Further Bolstering Patient Care
Unilabs, the leading diagnostic services provider, announced a partnership with Subtle Medical, a healthcare technology […]
Biosyntia Closes a 11.5 Million EUR Round to Launch World’s First Bio-based Vitamin B7
Biosyntia has secured a Series B funding round of 11.5 million euros from a strong […]
Thabor Therapeutics Secures €2 Million in Deep Tech Financing From Bpifrance
Thabor Therapeutics, a company developing an innovative treatment for patients living with chronic mucosal inflammatory […]
Nanoscope Therapeutics Appoints Michael Marquez as Chief Financial Officer
Nanoscope Therapeutics, Inc., a clinical-stage biotechnology company developing gene therapies to treat retinal degenerative diseases, […]
Skyhawk Announces Collaboration Agreement with Sanofi for Oncology and Immunology Targets
Skyhawk Therapeutics, Inc. today announced the signing of an exclusive worldwide collaboration agreement with Sanofi […]
Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer
Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable […]
Enosi Therapeutics Partners with Danuo Science Group to Accelerate Multiple Therapeutic Programs
Enosi Therapeutics, a Delaware Corporation, focused on providing industry-leading therapeutics for cancer and autoimmune diseases, […]
ProteoNic Announces Licensing of Its Premium 2G UNic™ Technology Platform for Production of Biologics to Fyonibio
ProteoNic BV, a leading provider of premium vector technology and services for efficient production of […]
Breakthrough Radiology AI Provider Annalise.ai Appoints Proven Global Healthcare Leader as CEO, Officially Launches US Team Following FDA Clearances
annalise.ai, the global radiology AI company with rapidly growing presence in Asia- Pacific, Europe and the United Kingdom, today […]
Mogrify and Astellas Announce Collaboration to Conduct Research on in Vivo Regenerative Medicine Approaches to Address Sensorineural Hearing Loss
Mogrify Limited (CEO: Darrin M. Disley, Ph.D., “Mogrify®”), a biopharmaceutical company transforming the lives of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more